Trials / Active Not Recruiting

Active Not RecruitingNCT06471868

Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC

An Open-label, Randomized, Multiple-dose, 2-sequence, 2-period, Crossover, Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetics of IY-HCR21 Compared to IY-MIC in Healthy Adult Volunteers

Status: Active Not Recruiting
Phase: Phase 1
Study type: Interventional
Enrollment: 60 (actual)

Sponsor: Il-Yang Pharm. Co., Ltd. · Industry
Sex: All
Age: 19 Years
Healthy volunteers: Accepted

Summary

This study evaluate the pharmacokinetic and safety of IY-HCR21

Detailed description

Phase 1 study to evaluate the safety and the pharmacokinetics of IY-HCR21 in healthy adult volunteers under multiple-dose condition

Conditions

Pharmacokinetics

Interventions

Type	Name	Description
DRUG	IY-HCR21	Betanechol 50mg
DRUG	IY-MIC	Betanechol 25mg

Timeline

Start date: 2024-06-10
Primary completion: 2024-06-25
Completion: 2024-07-02
First posted: 2024-06-24
Last updated: 2024-06-24

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06471868. Inclusion in this directory is not an endorsement.